Literature DB >> 11506485

Neuroblastoma in monozygotic twins--a case of probable twin-to-twin metastasis.

J Anderson1, H Kempski, L Hill, D Rampling, T Gordon, A Michalski.   

Abstract

Concordance for neuroblastoma in monozygotic twins has been reported only rarely, and the cause of the shared pathology has not been established. We describe a case of infant monozygotic twins developing tumours that were morphologically, clinically and molecularly indistinguishable, but with a delay of 6 months between times of presentation. Both tumours were metastatic and had amplification of MYCN and deletion at 1p36. Twin 1, who developed neuroblastoma first, had constitutional karyotype abnormalities in at least 5% of peripheral blood mononuclear cells involving 1p and 3p, and a deletion of 1q44 in 21% of cells. Twin 2 had a normal constitutional karyotype and lacked rearrangement or deletion of these regions. We propose an acquired neuroblastoma predisposition specific for twin 1, and in utero metastatic spread of tumour cells to twin 2 via the shared placental circulation. Copyright 2001 Cancer Research Campaign.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11506485      PMCID: PMC2364085          DOI: 10.1054/bjoc.2001.1979

Source DB:  PubMed          Journal:  Br J Cancer        ISSN: 0007-0920            Impact factor:   7.640


  20 in total

Review 1.  Involvement of chromosomes 1 and 17 in a case of neuroblastoma.

Authors:  E L Mitchell; K McNally; A Kelsey
Journal:  Pediatr Hematol Oncol       Date:  1996 Sep-Oct       Impact factor: 1.969

2.  Constitutional translocation t(1;17)(p36;q12-21) in a patient with neuroblastoma.

Authors:  G Laureys; F Speleman; G Opdenakker; Y Benoit; J Leroy
Journal:  Genes Chromosomes Cancer       Date:  1990-09       Impact factor: 5.006

3.  Monozygotic siblings discordant for neuroblastoma: etiologic implications.

Authors:  B H Kushner; L Helson
Journal:  J Pediatr       Date:  1985-09       Impact factor: 4.406

4.  Coordinate deletion of chromosome 3p and 11q in neuroblastoma detected by comparative genomic hybridization.

Authors:  C J Breen; A O'Meara; M McDermott; M Mullarkey; R L Stallings
Journal:  Cancer Genet Cytogenet       Date:  2000-07-01

5.  Neuroblastoma in a pair of identical twins.

Authors:  A F Mancini; P Rosito; G Faldella; L Serra; R Vallicelli; V Vecchi; F Vivarelli; G Paolucci
Journal:  Med Pediatr Oncol       Date:  1982

6.  Constitutional 1p36 deletion in a child with neuroblastoma.

Authors:  J A Biegel; P S White; H N Marshall; M Fujimori; E H Zackai; C D Scher; G M Brodeur; B S Emanuel
Journal:  Am J Hum Genet       Date:  1993-01       Impact factor: 11.025

7.  Fragile sites and neuroblastoma: fragile site at 1p13.1 and other points on lymphocyte chromosomes from patients and family members.

Authors:  B Rudolph; J Harbott; F Lampert
Journal:  Cancer Genet Cytogenet       Date:  1988-03

8.  Cytogenetic features of human neuroblastomas and cell lines.

Authors:  G M Brodeur; A A Green; F A Hayes; K J Williams; D L Williams; A A Tsiatis
Journal:  Cancer Res       Date:  1981-11       Impact factor: 12.701

9.  Abnormalities of chromosome 1p in human neuroblastoma tumors and cell lines.

Authors:  F Gilbert; G Balaban; P Moorhead; D Bianchi; H Schlesinger
Journal:  Cancer Genet Cytogenet       Date:  1982-09

10.  Loss of heterozygosity of 3p markers in neuroblastoma tumours implicate a tumour-suppressor locus distal to the FHIT gene.

Authors:  K Ejeskär; H Aburatani; J Abrahamsson; P Kogner; T Martinsson
Journal:  Br J Cancer       Date:  1998-06       Impact factor: 7.640

View more
  2 in total

1.  Constitutional 3p26.3 terminal microdeletion in an adolescent with neuroblastoma.

Authors:  Annalisa Pezzolo; Angela Rita Sementa; Margherita Lerone; Martina Morini; Marzia Ognibene; Raffaella Defferrari; Katia Mazzocco; Massimo Conte; Anna Rita Gigliotti; Alberto Garaventa; Vito Pistoia; Luigi Varesio
Journal:  Cancer Biol Ther       Date:  2017-04-12       Impact factor: 4.742

2.  SRARP and HSPB7 are epigenetically regulated gene pairs that function as tumor suppressors and predict clinical outcome in malignancies.

Authors:  Ali Naderi
Journal:  Mol Oncol       Date:  2018-04-16       Impact factor: 6.603

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.